Vect-horus

Peptide-vector drug development company focussing on blood-brain barrier technology for CNS and cancer applications

placeMarseille, Provence Alpes Cote D Azur, France calendar_todayFounded 2005 groups36 employees language vect-horus.com

Innovation

12 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 613 times.

YearFilings
20154
20163
20173
20182
20193
20203
20214
20223
20232
20247
20253
20262

Social engagement

Social engagement: 3.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Accelerator & incubator133%
Other / undisclosed267%

Recent activity

30 Jun 2026
Partnership
Sserver
9 Jun 2026
Event
BIO 2026
13 May 2026
Event
TIDES USA 2026
Coming soon